Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bio-Rad Labs Inc. A buy Royal Bank of Canada

Start price
€307.80
02.08.24 / 50%
Target price
€367.36
02.08.25
Performance (%)
0.00%
Price
€307.80
02.08.24
Summary
This prediction is currently active. Royal_Bank_of_Canada's BUY prediction for Bio-Rad Labs Inc. A is currently unchanged. This prediction currently runs until 02.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w
Bio-Rad Labs Inc. A 0.00%
iShares Core DAX® -1.377%
iShares Nasdaq 100 0.827%
iShares Nikkei 225® 0.198%
iShares S&P 500 1.364%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Bio-Rad Labs Inc. A diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 367.356
Change
Ends at 02.08.25

Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Royal Bank of Canada from $402.00 to $401.00. They now have an "outperform" rating on the stock.
Ratings data for BIO provided by MarketBeat

Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€316.20
16.02.24
€445.58
16.02.25
-2.66%
02.08.24

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€363.40
04.08.23
€474.64
04.08.24
-15.30%
02.08.24